ClinicalTrials.gg
Sign In
CompletedNCT07230275Updated Nov 17, 2025

Frailty Increase Rectal Prolapse Recurrence

An observational study in Rectal Prolapse, sponsored by Zagazig University. Completed. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2025-11-17.

Sponsored by Zagazig University · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
342
Ages
60 Years and older
Sex
All
01

Study summary

evaluate recurrent RP in relation to frailty

02

Conditions studied

  • Rectal Prolapse

Keywords

  • frailty
03

In context

Rectal Prolapse

55 studies on the registry are indexed under Rectal Prolapse; 12 are open to participants now.

This study's enrollment of 342 is above the median of 200 across 21 observational studies indexed under Rectal Prolapse.

Browse Rectal Prolapse studies →

Lead sponsor

Zagazig University is the lead sponsor of 459 studies on the registry; 77 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Browse Zagazig University studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

elderly patients with RP

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • EPs aged ≥60 years EFTRP (Oxford prolapse grade 5)

Exclusion criteria

Exclusion Criteria:

    • aged \< 60 years

      • incomplete medical records,
      • concurrent colorectal procedures,
      • multi-compartmental prolapse requiring combined operations,
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
342 participants (actual)
Patient registry
No

Groups and cohorts

  • laparoscopic ventral rectopexy

    LVMR for management of rectal prolapse

    Procedure: LVMR for RP

  • perineal stapler resection

    PSR for management of RP

    Procedure: PSR for RP

Interventions

  • ProcedureLVMR for RP

    LVMR for management of RP

  • ProcedurePSR for RP

    PSR for management of RP

06

What researchers measure

Primary outcomes

  1. recurrence in relation to frailty

    Time frame: 5 years

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2014 to primary completion in Oct 2020, 72 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 13, 2025
First posted
Nov 17, 2025
StartActual
Oct 1, 2014
Primary completionActual
Oct 1, 2020
CompletionActual
Oct 1, 2025
Last update
Nov 17, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07230275
Lead sponsor
Zagazig University
Responsible party
Tamer.A.A.M.Habeeb (prof, Zagazig University) — Principal investigator
First posted
Nov 17, 2025
Start date
Oct 1, 2014
Primary completion
Oct 1, 2020
Completion
Oct 1, 2025
Last update
Nov 17, 2025

Study contacts

Tamer.A.A.M. Habeeb
principal investigator · Zagazig University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Rectal Prolapse →

Other studies from this sponsor

Zagazig University →

Start the discussion